
Sonya N. Wright
Examiner (ID: 11509, Phone: (571)272-5857 , Office: P/1672 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1621, 1626, 1672, 1613, 1762, 1796, 1614 |
| Total Applications | 765 |
| Issued Applications | 560 |
| Pending Applications | 32 |
| Abandoned Applications | 177 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6835252
[patent_doc_number] => 20030162798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments'
[patent_app_type] => new
[patent_app_number] => 10/378913
[patent_app_country] => US
[patent_app_date] => 2003-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12417
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10378913
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/378913 | Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments | Mar 4, 2003 | Abandoned |
Array
(
[id] => 6825785
[patent_doc_number] => 20030236407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Perfluoroalkyl group-containing micelle-forming triiodoaromatic compounds, process for their production and their use as contrast media'
[patent_app_type] => new
[patent_app_number] => 10/375044
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9821
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20030236407.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375044
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375044 | Perfluoroalkyl group-containing micelle-forming triiodoaromatic compounds, process for their production and their use as contrast media | Feb 27, 2003 | Abandoned |
Array
(
[id] => 7368018
[patent_doc_number] => 20040006091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Therapeutic agents useful for treating or preventing pain'
[patent_app_type] => new
[patent_app_number] => 10/374863
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28484
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006091.pdf
[firstpage_image] =>[orig_patent_app_number] => 10374863
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/374863 | 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain | Feb 26, 2003 | Issued |
Array
(
[id] => 1050143
[patent_doc_number] => 06861422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-01
[patent_title] => 'Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/374876
[patent_app_country] => US
[patent_app_date] => 2003-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16938
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/861/06861422.pdf
[firstpage_image] =>[orig_patent_app_number] => 10374876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/374876 | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions | Feb 25, 2003 | Issued |
Array
(
[id] => 7362332
[patent_doc_number] => 20040014768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Chromenone derivatives and their use for treating diseases in conjunction with 5-hta1receptors and/or dopamine d2 receptors'
[patent_app_type] => new
[patent_app_number] => 10/362236
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4876
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014768.pdf
[firstpage_image] =>[orig_patent_app_number] => 10362236
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/362236 | Chromenone derivatives and their use for treating diseases in conjunction with 5-hta1receptors and/or dopamine d2 receptors | Feb 20, 2003 | Abandoned |
Array
(
[id] => 6847449
[patent_doc_number] => 20030166616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Novel 2-phenylpiperazine derivatives'
[patent_app_type] => new
[patent_app_number] => 10/370918
[patent_app_country] => US
[patent_app_date] => 2003-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14701
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166616.pdf
[firstpage_image] =>[orig_patent_app_number] => 10370918
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/370918 | 2-phenylpiperazine derivatives | Feb 19, 2003 | Issued |
Array
(
[id] => 7398189
[patent_doc_number] => 20040038987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Novel cyclic diamine compounds and medicine containing the same'
[patent_app_type] => new
[patent_app_number] => 10/371234
[patent_app_country] => US
[patent_app_date] => 2003-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63792
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038987.pdf
[firstpage_image] =>[orig_patent_app_number] => 10371234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/371234 | Cyclic diamine compounds and medicine containing the same | Feb 19, 2003 | Issued |
Array
(
[id] => 1139935
[patent_doc_number] => 06780993
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-24
[patent_title] => 'Preparation of deazaguanine analog'
[patent_app_type] => B1
[patent_app_number] => 10/367950
[patent_app_country] => US
[patent_app_date] => 2003-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5122
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/780/06780993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10367950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/367950 | Preparation of deazaguanine analog | Feb 18, 2003 | Issued |
Array
(
[id] => 716453
[patent_doc_number] => 07053214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-30
[patent_title] => 'β-sheet mimetics and composition and methods relating thereto'
[patent_app_type] => utility
[patent_app_number] => 10/367575
[patent_app_country] => US
[patent_app_date] => 2003-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16086
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/053/07053214.pdf
[firstpage_image] =>[orig_patent_app_number] => 10367575
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/367575 | β-sheet mimetics and composition and methods relating thereto | Feb 13, 2003 | Issued |
Array
(
[id] => 708237
[patent_doc_number] => 07060840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'Catalytic asymmetric desymmetrization of prochiral compounds'
[patent_app_type] => utility
[patent_app_number] => 10/366581
[patent_app_country] => US
[patent_app_date] => 2003-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9386
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10366581
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/366581 | Catalytic asymmetric desymmetrization of prochiral compounds | Feb 12, 2003 | Issued |
Array
(
[id] => 6865542
[patent_doc_number] => 20030191068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them'
[patent_app_type] => new
[patent_app_number] => 10/365327
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5615
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191068.pdf
[firstpage_image] =>[orig_patent_app_number] => 10365327
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/365327 | Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them | Feb 11, 2003 | Issued |
Array
(
[id] => 6852329
[patent_doc_number] => 20030144532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Method of manufacture of 1,3-oxathiolane nucleosides'
[patent_app_type] => new
[patent_app_number] => 10/361980
[patent_app_country] => US
[patent_app_date] => 2003-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12026
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10361980
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/361980 | Process of manufacture of 1,3-oxathiolane nucleosides using titanium trichloride mono-isopropoxide | Feb 10, 2003 | Issued |
Array
(
[id] => 7605187
[patent_doc_number] => 07115742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Process for the preparation of triethylenediamine (TEDA) from ethylenediamine'
[patent_app_type] => utility
[patent_app_number] => 10/359244
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8936
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115742.pdf
[firstpage_image] =>[orig_patent_app_number] => 10359244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/359244 | Process for the preparation of triethylenediamine (TEDA) from ethylenediamine | Feb 5, 2003 | Issued |
Array
(
[id] => 7398160
[patent_doc_number] => 20040038982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Compounds and methods'
[patent_app_type] => new
[patent_app_number] => 10/343880
[patent_app_country] => US
[patent_app_date] => 2003-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21864
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038982.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343880
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343880 | Compounds and methods | Feb 4, 2003 | Abandoned |
Array
(
[id] => 6835240
[patent_doc_number] => 20030162786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein'
[patent_app_type] => new
[patent_app_number] => 10/356862
[patent_app_country] => US
[patent_app_date] => 2003-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8736
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162786.pdf
[firstpage_image] =>[orig_patent_app_number] => 10356862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/356862 | Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein | Feb 2, 2003 | Issued |
Array
(
[id] => 7136290
[patent_doc_number] => 20040044003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Therapeutic agents useful for treating pain'
[patent_app_type] => new
[patent_app_number] => 10/355186
[patent_app_country] => US
[patent_app_date] => 2003-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38885
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20040044003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10355186
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/355186 | 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain | Jan 30, 2003 | Issued |
Array
(
[id] => 6822158
[patent_doc_number] => 20030220319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Substituted indoles as alpha-1 agonists'
[patent_app_type] => new
[patent_app_number] => 10/355588
[patent_app_country] => US
[patent_app_date] => 2003-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28679
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220319.pdf
[firstpage_image] =>[orig_patent_app_number] => 10355588
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/355588 | Substituted indoles as alpha-1 agonists | Jan 30, 2003 | Issued |
Array
(
[id] => 6805470
[patent_doc_number] => 20030232864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Novel Compounds and compositions as protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/354888
[patent_app_country] => US
[patent_app_date] => 2003-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59316
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232864.pdf
[firstpage_image] =>[orig_patent_app_number] => 10354888
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/354888 | Novel Compounds and compositions as protease inhibitors | Jan 27, 2003 | Abandoned |
Array
(
[id] => 6770471
[patent_doc_number] => 20030216411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'
[patent_app_type] => new
[patent_app_number] => 10/353806
[patent_app_country] => US
[patent_app_date] => 2003-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13431
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10353806
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/353806 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Jan 27, 2003 | Abandoned |
Array
(
[id] => 6725576
[patent_doc_number] => 20030207888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Piperazine derivatives'
[patent_app_type] => new
[patent_app_number] => 10/350616
[patent_app_country] => US
[patent_app_date] => 2003-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34094
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207888.pdf
[firstpage_image] =>[orig_patent_app_number] => 10350616
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/350616 | 1,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivatives | Jan 23, 2003 | Issued |